Individualized strategy for clopidogrel suspension in patients undergoing off-pump coronary surgery for acute coronary syndrome: A case-control study

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 4, 2014, Pages 1299-1306

  Mannacio, Vito ^a   Meier, Pascal ^b,c   Antignano, Anita ^d   Di Tommaso, Luigi ^a   De Amicis, Vincenzo ^a   Vosa, Carlo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; SUSPENSION; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; POINT OF CARE PLATELET FUNCTION TESTING; POINT OF CARE TESTING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PROPENSITY SCORE; PROSPECTIVE STUDY; REOPERATION; SUSPENSION; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; ANALOGS AND DERIVATIVES; MIDDLE AGED; RISK FACTOR;

ACUTE CORONARY SYNDROME; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PROPENSITY SCORE; PROSPECTIVE STUDIES; RISK FACTORS; SUSPENSIONS; TICLOPIDINE;

EID: 84908230265     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.12.011     Document Type: Article

References (27)

1. G.N. Levine, E.R. Bates, J.C. Blankenship, S.R. Bailey, J.A. Bittl, and B. Cercek 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 122
2. H. Jneid, J.L. Anderson, R.S. Wright, C.D. Adams, C.R. Bridges, and D.E. Casey Jr 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 60 2012 645 681
3. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, F. Alfonso, C. Macaya, and T.A. Bass Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516
4. L.D. Hillis, P.K. Smith, J.L. Anderson, J.A. Bittl, C.R. Bridges, and J.G. Byrne 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Thorac Cardiovasc Surg 143 2012 4 34
5. V.A. Ferraris, S.P. Saha, and J.H. Oestreich 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations Ann Thorac Surg 94 2012 1761 1781
6. C.V. Pollack Jr., J.E. Hollander, A.Y. Chen, E.D. Peterson, S. Bangalore, and F.W. Peacock Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiative Crit Pathw Cardiol 8 2009 29 33
7. L.T. Goodnough, P.K. Smith, J.H. Levy, R.S. Poston, M.A. Short, and G.J. Weerakkody Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis J Thorac Cardiovasc Surg 145 2013 1077 1082
8. C.E. Firanescu, E.J. Martens, J.P. Schönberger, M.A. SolimanHamad, and A.H. van Straten Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study Eur J Cardiothorac Surg 36 2009 856 862
9. J.K. Shim, Y.S. Choi, Y.J. Oh, S.O. Bang, K.J. Yoo, and Y.L. Kwak Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery J Thorac Cardiovasc Surg 134 2007 59 64
10. S.S. Nijjer, G. Watson, T. Athanasiou, and I.S. Malik Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies Eur Heart J 32 2011 2970 2988
11. G.N. Vaccarino, J. Thierer, M. Albertal, M. Vrancic, F. Piccinini, and M. Benzadón Impact of preoperative clopidogrel in off pump coronary artery bypass surgery: a propensity score analysis J Thorac Cardiovasc Surg 137 2009 309 313
12. J.Y. Leong, R.A. Baker, P.J. Shah, V.K. Cherian, and J.L. Knight Clopidogrel and bleeding after coronary artery bypass graft surgery Ann Thorac Surg 80 2005 928 933
13. V.A. Mannacio, L. Di Tommaso, A. Antignano, V. De Amicis, and C. Vosa Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study Heart 98 2012 1710 1715
14. V.A. Ferraris, S.P. Ferraris, S.P. Saha, E.A. Hessel II, C.K. Haan, and B.D. Royston Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline Ann Thorac Surg 83 5 Suppl 2007 S27 S86
15. J.A. Jakubowski, C.D. Payne, Y.G. Li, J.T. Brandt, D.S. Small, and N.A. Farid The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration Thromb Haemost 99 2008 409 415
16. A. Tsantes, I. Ikonomidis, I. Papadakis, C. Kottaridi, A. Tsante, and E. Kalamara Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance Platelets 23 2012 481 489
17. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, and T. Folliguet Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the ESC/EACTS Eur Heart J 31 2010 2501 2555
18. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, H.D. White the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction Third universal definition of myocardial infarction J Am Coll Cardiol 60 2012 1581 1598
19. V. Mannacio, L. Di Tommaso, V. De Amicis, P. Stassano, F. Musumeci, and C. Vosa Preoperative intraaortic balloon pump for off-pump coronary arterial revascularization Ann Thorac Surg 93 2012 804 809
20. V.A. Ferraris, J.R. Brown, G.J. Despotis, J.W. Hammon, T.B. Reece, and S.P. Saha 2011 Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines Ann Thorac Surg 91 2011 944 982
21. D. Paparella, A. Galeone, M.T. Venneri, M. Coviello, G. Scrascia, and N. Marraudino Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques J Thorac Cardiovasc Surg 131 2006 290 297
22. L. Englberger, F.F. Immer, F.S. Eckstein, P.A. Berdat, A. Haeberli, and T.P. Carrel Off-pump coronary artery bypass operation does not increase procoagulant and fibrinolytic activity: preliminary results Ann Thorac Surg 77 2004 1560 1566
23. M.J. Price, J.S. Walder, B.A. Baker, D.E. Heiselman, J.A. Jakubowski, and D.K. Logan Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial J Am Coll Cardiol 59 2012 2338 2343
24. M. Ranucci, S. Aronson, W. Dietrich, C.M. Dyke, A. Hofmann, and K. Karkouti Patient blood management during cardiac surgery: do we have enough evidence for clinical practice? J Thorac Cardiovasc Surg 142 2011 249.e1 249.e32
25. K.A. Fox, S.R. Mehta, R. Peters, F. Zhao, N. Lakkis, and B.J. Gersh Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Circulation 110 2004 1202 1208
26. D.J. LaPar, I.K. Crosby, G. Ailawadi, N. Ad, E. Choi, and B.D. Spiess Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery J Thorac Cardiovasc Surg 145 2013 796 803
27. R. Ascione, A. Ghosh, C. Rogers, A. Cohen, C. Monk, and G.D. Angelini In hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution Ann Thorac Surg 79 2005 1210 1216